Search Constraints
Search Results
Select an image to start the slideshow
Strategies for engineering γδ T cells to treat pediatric cancers
1 of 10
Optimizing the Manufacturing and Efficacy of Gamma Delta T Cell Immunotherapies for the Treatment of Cancer
2 of 10
Evolutionary approaches to coagulation factor VIII biopharmaceutical engineering
3 of 10
Optimizing the Testing of VLR-CAR in Lymphoid Cells
4 of 10
The Complexity of the Humoral Immune Response to Factor VIII in Hemophilia A
5 of 10
Bioengineering Viral Transgenes for the Treatment of the Hemophilias
6 of 10
The Interplay Between Reverse Transcription and SAMHD1 Degradation: Mechanistic Differences Between Reverse Transcriptases from HIV-1, HIV-2 and SIV Lentiviruses Able or Unable to Degrade SAMHD1
7 of 10
A dip IN the shallow end: SAMHD1 dNTPase specificity and how draining the dNTP pool limits HIV-1 gap repair.
8 of 10
Examination of the Immunological Aspects of Gene Therapy for the Treatment of Hemophilia A
9 of 10
Novel immunogen-specific variable lymphocyte receptors for creation of chimeric antigen receptors and methods for improved transduction and gene delivery
10 of 10